Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 4 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Peritoneal Diseases 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Diseases 1 Neuroblastoma 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Mesothelioma, Malignant 1 Lymphoma 1 Liver Neoplasms 1 Leukemia 1

Interventions

Gemcitabine 15 Doxorubicin 8 Docetaxel 8 Radiotherapy 7 Trabectedin 6 Nivolumab 5 pazopanib 4 liposomal doxorubicin 3 Sunitinib 3 Dacarbazine 3 pembrolizumab 2 eribulin 2 durvalumab 2 avelumab 2 Specimen Handling 2 Radiation Dose Hypofractionation 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tremelimumab 1 temsirolimus 1 sotigalimab 1 selinexor 1 sargramostim 1 rucaparib 1 ribociclib 1 regorafenib 1 pegfilgrastim 1 olaratumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma × Tissue Banks × Clear all

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡